Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

SOLACE Trial - A Phase 3 Trial in Subjects With Non-infectious Anterior-uveitis.

ClinicalTrials.gov ID: NCT03131154

Public ClinicalTrials.gov record NCT03131154. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 9:39 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-masked, Vehicle-controlled Trial to Evaluate the Safety and Efficacy of ADX-102 Ophthalmic Solution in Subjects With Non-infectious Anterior-uveitis.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Phase 3, randomized, double-masked, vehicle-controlled trial to evaluate the safety and efficacy of ADX-102 ophthalmic solution in Subjects with non-infectious anterior-uveitis.

Study identification

NCT ID
NCT03131154
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Aldeyra Therapeutics, Inc.
Industry
Enrollment
123 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 26, 2017 (Actual)
Primary completion
Apr 19, 2019 (Actual)
Completion
Apr 26, 2019 (Actual)
Last update posted
Feb 10, 2025

2017 – 2019

United States locations

U.S. sites
27
U.S. states
16
U.S. cities
27
Facility City State ZIP Site status
UAB Department of Ophthalmology Birmingham Alabama 35233 —
Retinal Research Institute Phoenix Arizona 85014 —
M&M Eye Institute Prescott Arizona 86301 —
Walman Eye Center Sun City Arizona 85351 —
Retina-Vitreous Associates Medical Group Beverly Hills California 90211 —
University of California, Irvine Irvine California 92697 —
Byers Eye Institute at Stanford University Palo Alto California 85014 —
Retinal Consultants Medical Group, Inc. Sacramento California 95819 —
Corneal Consultants of Colorado Littleton Colorado 80120 —
Danbury Eye Physicians & Surgeons Danbury Connecticut 06810 —
Levenson Eye Associates Jacksonville Florida 33204 —
Center for Retina and Macular Disease Winter Haven Florida 33880 —
Midwest Eye Institute Indianapolis Indiana 46290 —
John Hopkins Baltimore Maryland 21205 —
Valley Eye Physicians & Surgeons Ayer Massachusetts 01432 —
Ophthalmic Consultants of Boston Boston Massachusetts 02114 —
Ocular Immunology & Uveitis Foundation Waltham Massachusetts 02451 —
Oakland Ophthalmic Surgery Birmingham Michigan 48009 —
Tauber Eye Center Kansas City Missouri 64111 —
Metropolitan Eye Research and Surgery Institute Palisades Park New Jersey 07650 —
Bergstrom Eye Research Fargo North Dakota 58103 —
Oregon Retina, LLP Eugene Oregon 97401 —
Texas Retina Associates Dallas Texas 75231 —
Retina Consultants of Houston Houston Texas 77030 —
Retina and Uveitis Consultants of Texas San Antonio Texas 78240 —
Retina Consultants of Houston The Woodlands Texas 77384 —
Virginia Eye Consultants Norfolk Virginia 23502 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03131154, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 10, 2025 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03131154 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →